Disc Medicine posts Q2 GAAP EPS of -$1.54, beating estimates by $0.19

Earnings
โดย Seeking Alpha·Read original
Summary · why it matters

Disc Medicine reported second-quarter 2026 GAAP earnings per share of -$1.54, surpassing consensus estimates by $0.19. The company ended the quarter with approximately $718 million in cash, cash equivalents, and marketable securities, which it expects will fund operations into 2029.

Impact on stocks 1

Health Care▲ · 1 stocks
Disc Medicine Inc.
IRON
▲ PositiveCapitalrelevance

Q2 GAAP EPS beat estimates by $0.19 and cash runway extended into 2029

© 2026 MarketDXNews